Satoshi Hirooka Selected Research

Satoshi Hirooka Research Topics

13	Adenocarcinoma 03/2022 - 04/2012
10	Neoplasms (Cancer) 06/2022 - 01/2008
9	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 11/2010
6	Pancreatic Fistula (Pancreatic Fistulas) 01/2019 - 01/2011
4	Neoplasm Metastasis (Metastasis) 03/2022 - 04/2011
3	Cholangitis 11/2022 - 01/2014
3	Cholelithiasis 01/2020 - 01/2019
2	Lymphatic Metastasis 06/2022 - 05/2020
2	Non-alcoholic Fatty Liver Disease 03/2016 - 03/2014
1	Pathologic Constriction (Stenosis) 11/2022
1	Cholecystolithiasis 01/2020
1	Pancreatitis 04/2019
1	Carcinoma (Carcinomatosis) 04/2019
1	Edema (Dropsy) 04/2019
1	Gallbladder Diseases (Gall Bladder Disease) 04/2019
1	Acute Cholecystitis 04/2019
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2019
1	Infections 01/2018
1	Ascites 01/2017
1	Diarrhea 01/2017
1	Median Arcuate Ligament Syndrome 12/2016
1	Neutropenia 01/2016
1	Fatigue 01/2016
1	Abdominal Abscess 01/2014
1	Cysts 11/2013
1	Fibrosis (Cirrhosis) 02/2013

3	CarbohydratesIBA 02/2022 - 04/2011
3	Gemcitabine FDA Link 05/2017 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 05/2017
2	Active Hexose Correlated CompoundIBA 11/2021 - 01/2016
2	AntigensIBA 07/2021 - 04/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2014
2	EnzymesIBA 03/2016 - 03/2014
2	Pancrelipase (Creon)FDA Link 03/2016 - 03/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 02/2013
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 02/2022
1	Immunologic Factors (Immunomodulators)IBA 11/2021
1	Perilipin-2IBA 04/2019
1	Indicators and Reagents (Reagents)IBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	RNA (Ribonucleic Acid)IBA 04/2019
1	CytokinesIBA 04/2019
1	folfirinoxIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 09/2014
1	Angiotensin IIIBA 08/2014
1	Angiotensin II Type 1 Receptor BlockersIBA 08/2014
1	Losartan (Cozaar)FDA LinkGeneric 08/2014
1	A 19IBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2011
1	Polyglycolic Acid (Polyglycolide)IBA 01/2011
1	Prostaglandins AIBA 01/2011
1	Serum AlbuminIBA 01/2008

8	Pancreaticoduodenectomy 11/2022 - 01/2014
8	Drug Therapy (Chemotherapy) 03/2022 - 02/2013
6	Pancreatectomy 05/2017 - 04/2012
5	Therapeutics 05/2017 - 11/2010
4	Neoadjuvant Therapy 11/2021 - 11/2010
3	Adjuvant Chemotherapy 06/2022 - 01/2017
3	Cholecystectomy 01/2020 - 01/2019
2	Laparotomy 03/2022 - 04/2011
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 01/2016
2	Length of Stay 01/2019 - 01/2014
2	Pancreaticojejunostomy 01/2019 - 01/2011
2	Laparoscopic Cholecystectomy 01/2019 - 01/2018
1	Preoperative Period 11/2022
1	Jejunostomy 11/2022
1	Chemoradiotherapy 05/2020
1	Combined Modality Therapy 05/2020
1	Aftercare (After-Treatment) 02/2013